Synthesis and characterization of mercapturic acid (N-acetyl-L-cysteine)- aflatoxin B1 adduct and its quantitation in rat urine by an enzyme immunoassay

Abstract

A simple and sensitive indirect noncompetitive enzyme immunoassay to quantitate mercapturic acid-aflatoxin B1 (AFB1) adduct in rat urine is reported. A novel procedure was developed for in vitro synthesis of an immunogen, bovine serum albumen-glutathione-aflatoxin B1 (BSA-GSH-AFB1) using 1 -ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride. Sulphydryl group's analysis confirmed the conjugation of-SH groups to AFB1. Thin-layer chromatography and spectral analysis (absorption, fluorescence, and Fourier transform infrared) of the conjugates further confirmed the formation of the adducts. Polyclonal antibodies specific to mercapturic acid-AFB1 adduct were produced against BSA-GSH-AFB1. The assay was found to be linear in the range of 100 pg-100 ng of the analyte (y = a + bx). A 50% displacement of BSA-GSH-AFBi antibodies was achieved at an inhibitory concentration (IC50) of 11.9 ng GSH-AFB1 (r1 = 0.98) and 1.22 ng N-acetyl-L-cysteine (NAC)-AFB1 (z1 = 0.98). Spiking 5 μg/mL of reference standard to the control rat urine showed a recovery of 98 ± 2%. The immunoassay was validated in a rodent model exposed to a single oral dose of 1 mg/kg body mass of pure AFB1. The excretion of NAC-AFB1 adduct was quantitated at the end of 24 h. The concentration of the NAC-AFB 1 adduct excreted in urine as determined by the immunoassay was found to be in the range of 3.22-5.97 μg/mg creatinine. The present method may find wide application as a biochemical tool in molecular epidemiological and intervention studies with respect to human exposure to dietary aflatoxins.